Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_105ede3f18a37a03da255f54e6dd2067 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2549-119 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-686 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-027 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2015-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97134fc815bf5da73e87ed93776e4aa1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8e6e24b8d9d82b0a270e8e0f2cf1bd9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a21d1496bfb790d7aa82def71616a689 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_891666ac4f30e48e25360747c4973682 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ada749c530adb6a3a5a1c55c96e20e66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69925af4fc7629566659df08d29a7301 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74ea4809ef48aff8d943ab3921eed445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_468fe24ae9e68d7a972e4bcaeef6b5ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86eaf9d92af3d4e92edf2aefca4f9605 |
publicationDate |
2017-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20170006690-A |
titleOfInvention |
Management Strategy for Aquaculturing Sevenband Grouper with Resistance to Viral Nervous Necrosis |
abstract |
The present invention relates to a step (Aa) of selecting neurons of non-infectious neurons of nerve necrosis virus by an improved ELISA method and a step (Aa) of optimized Nested-PCR (A) blocking the vertical infection pathway including the step of selecting the nerve necrosis virus non-infectious egg or spermatozoa (Ab) and the step (A) of the nasal necrosis virus non- Viral neuro-necrosis (Ba), which is produced by the virulent progeny, and step (Bb), which is produced by the immunostimulant administration of viral neuro-necrosis and disease- (B). ≪ RTI ID = 0.0 > It provides a method for the production and acronyms can be supplied to prevent the loss of farms in the form of a stable high-quality life. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108251356-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108251356-A |
priorityDate |
2015-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |